STAT Plus (8/30, Robbins, Subscription Publication) reports the first digital tablet that can alert a patient’s physician or caregiver after it has been swallowed will soon enter the market and be first sold to people with mental illness who are covered by Medicaid. The product will cost $1,650 per month. The digital pill was approved last year by the FDA “for patients with schizophrenia and bipolar disorder,” and “it’s a high-tech upgrade to the antipsychotic drug Abilify.”
Related Links:
— “At $1,650 per month, the first digital pill will soon roll out to certain Medicaid patients with mental illness, “Rebecca Robbins, STAT Plus , August 30, 2018.